Related references
Note: Only part of the references are listed.PPAR-γ agonists inhibit profibrotic phenotypes in human lung fibroblasts and bleomycin-induced pulmonary fibrosis
Jami E. Milam et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2008)
Amp-activated protein kinase activation as a strategy for protecting vascular endothelial function
Ming-Hui Zou et al.
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (2008)
High glucose activates PKC-zeta and NADPH oxidase through autocrine TGF-beta(1) signaling in mesangial cells
Ling Xia et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2008)
Rosiglitazone reduces glucose-induced oxidative stress mediated by NAD(P)H oxidase via AMPK-dependent mechanism
Giulio Ceolotto et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2007)
Reactive oxygen species, PKC-β1, and PKC-ξ mediate high-glucose-induced vascular endothelial growth factor expression in mesangial cells
Ling Xia et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2007)
The PPARγ ligand, rosiglitazone, reduces vascular oxidative stress and NADPH oxidase expression in diabetic mice
Jinah Hwang et al.
VASCULAR PHARMACOLOGY (2007)
Synergistic vascular protective effects of combined low doses of PPARα and PPARγ activators in angiotensin II-induced hypertension in rats
C. De Ciuceis et al.
BRITISH JOURNAL OF PHARMACOLOGY (2007)
Thiazolidinedione ameliorates renal injury in experimental diabetic rats through anti-inflammatory effects mediated by inhibition of NF-κB activation
Sakiko Ohga et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2007)
Rosiglitazone prevents advanced glycation end products-induced renal toxicity likely through suppression of plasminogen activator inhibitor-1
Xiaoyan Yu et al.
TOXICOLOGICAL SCIENCES (2007)
Troglitazone and pioglitazone interactions via PPAR-γ-independent and -dependent pathways in regulating physiological responses in renal tubule-derived cell lines
Francesco Turturro et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2007)
Rosiglitazone treatment enhances acute AMP-activated protein kinase-mediated muscle and adipose tissue glucose uptake in high-fat-fed rats
Ji-Ming Ye et al.
DIABETES (2006)
Peroxisomal proliferator-activated receptor-γ agonists induce partial reversion of epithelial-mesenchymal transition in anaplastic thyroid cancer cells
Aurora Aiello et al.
ENDOCRINOLOGY (2006)
PPAR-α and -γ agonists attenuate diabetic kidney disease in the apolipoprotein E knockout mouse
Anna C. Calkin et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2006)
Thiazolidinediones ameliorate diabetic nephropathy via cell cycle-dependent mechanisms
Tatsuo Okada et al.
DIABETES (2006)
PPARα agonist fenofibrate improves diabetic nephropathy in db/db mice
CW Park et al.
KIDNEY INTERNATIONAL (2006)
Accelerated diabetic nephropathy in mice lacking the peroxisome proliferator-activated receptor α
CW Park et al.
DIABETES (2006)
Mesangial cell NADPH oxidase upregulation in high glucose is protein kinase C dependent and required for collagen IV expression
L Xia et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2006)
Proline oxidase, a proapoptotic gene, is induced by troglitazone -: Evidence for both peroxisome proliferator-activated receptor γ-dependent and -independent mechanisms
J Pandhare et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Peroxisome proliferator-activated receptor γ suppresses proximal α1(I) collagen promoter via inhibition of p300-facilitated NF-I binding to DNA in hepatic stellate cells
S Yavrom et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
PPARγ agonists exert antifibrotic effects in renal tubular cells exposed to high glucose
U Panchapakesan et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2005)
Drug Insight: thiazolidinediones and diabetic nephropathy - relevance to renoprotection
U Panchapakesan et al.
NATURE CLINICAL PRACTICE NEPHROLOGY (2005)
PPARγ agonists diminish serum VEGF elevation in diet-induced insulin resistant SD rats and ZDF rats
BC Yang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2005)
Pioglitazone attenuates TGF-β1-induction of fibronectin synthesis and its splicing variant in human mesangial cells via activation of peroxisome proliferator-activated receptor (PPAR)γ
A Maeda et al.
CELL BIOLOGY INTERNATIONAL (2005)
Pioglitazone inhibits cell growth and reduces matrix production in human kidney fibroblasts
S Zafiriou et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2005)
Rapid change of glucose concentration promotes mesangial cell proliferation via VEGF: inhibitory effects of thiazolidinedione
A Onozaki et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2004)
Peroxisome proliferator-activated receptor γ induces a phenotypic switch from activated to quiescent hepatic stellate cells
S Hazra et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
PPARα activators inhibit vascular endothelial growth factor receptor-2 expression by repressing Sp1-dependent DNA binding and transactivation
M Meissner et al.
CIRCULATION RESEARCH (2004)
Peroxisome proliferator-activated receptor γ ligands inhibit Rho/Rho kinase pathway by inducing protein tyrosine phosphatase SHP-2
S Wakino et al.
CIRCULATION RESEARCH (2004)
Stimulators of AMP-activated protein kinase inhibit the respiratory burst in human neutrophils
G Alba et al.
FEBS LETTERS (2004)
Peroxisome proliferator-activated receptor-gamma ligands inhibit TGF-beta 1-induced fibronectin expression in glomerular mesangial cells
BL Guo et al.
DIABETES (2004)
Extracellular matrix metabolism in diabetic nephropathy
RM Mason et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2003)
Overview of glucose signaling in mesangial cells in diabetic nephropathy
M Haneda et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2003)
Early stimulation and late inhibition of peroxisome proliferator-activated receptor γ (PPARγ) gene expression by transforming growth factor β in human aortic smooth muscle cells:: role of early growth-response factor-1 (Egr-1), activator protein 1 (AP1) and Smads
MG Fu et al.
BIOCHEMICAL JOURNAL (2003)
Phosphorylation of p47phox sites by PKC α, βII, δ, and ζ:: Effect on binding to p22phox and on NADPH oxidase activation
A Fontayne et al.
BIOCHEMISTRY (2002)
PPAR activators inhibit endothelial cell migration by targeting Akt
S Goetze et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2002)
The role of PPARs in the transcriptional control of cellular processes
YF Guan et al.
DRUG NEWS & PERSPECTIVES (2002)
Transcription suppression of thromboxane receptor gene by peroxisome proliferator-activated receptor-γ via an interaction with Sp1 in vascular smooth muscle cells
A Sugawara et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Degradation of the peroxisome proliferator-activated receptor γ is linked to ligand-dependent activation
S Hauser et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Peroxisome proliferator-activated receptor γ1 (PPARγ1) expresses in rat mesangial cells and PPARγ agonists modulate its differentiation
T Asano et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2000)
Glomerular type IV collagen in patients with diabetic nephropathy with and without additional glomerular disease
SG Adler et al.
KIDNEY INTERNATIONAL (2000)
Share Paper
